Pinoresinol inhibits proliferation and induces differentiation on human HL60 leukemia cells

Nutrition and Cancer

Volumn 65, Issue 8, 2013, Pages 1208-1218

  Sepporta, Maria Vittoria ^a   Mazza, Teresa ^a   Morozzi, Guido ^a   Fabiani, Roberto ^a  

^a UNIVERSITY OF PERUGIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 1; MESSENGER RNA; PINORESINOL; PROTEIN P53;

ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; ARTICLE; BREAST CANCER; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL DIFFERENTIATION; CELL PROLIFERATION; COLON CANCER; CONTROLLED STUDY; DRUG EFFECT; HUMAN; HUMAN CELL; LEUKEMIA CELL; PROSTATE CANCER; RECEPTOR UPREGULATION;

ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL DIFFERENTIATION; CELL LINE, TUMOR; CELL PROLIFERATION; CYCLIN-DEPENDENT KINASE INHIBITOR P21; DRUG RESISTANCE, NEOPLASM; FURANS; G1 PHASE; HL-60 CELLS; HUMANS; INHIBITORY CONCENTRATION 50; LIGNANS; S PHASE; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84888319470     PISSN: 01635581     EISSN: 15327914     Source Type: Journal    
DOI: 10.1080/01635581.2013.828089     Document Type: Article

References (45)

1. Pelucchi C, Bosetti C, Rossi M, Negri E, and LaVecchia C: Selected aspects of Mediterranean diet and cancer risk. Nutr Cancer 61, 756-766, 2009.
2. B́eliveau R, and Gingras D: Role of nutrition in preventing cancer. Can Fam Physician 53, 1905-1911, 2007.
3. Aggarwal BB, and Shishodia S: Molecular targets of dietary agents for prevention and therapy of cancer. Biochem Pharmacol 71, 1397-1421, 2006.
4. Adlercreutz H: Lignans and human health. Crit Rev Clin Lab Sci 44, 483-525, 2007.
5. Saleem M, Kim HJ, Ali MS, and Lee YS: An update on bioactive plant lignans. Nat Prod Rep 22, 696-716, 2005.
6. Peterson J, Dwye J, Adlercreuts H, Scalbert A, Jacques P, et al.: Dietary lignans: physiology and potential for cardiovascular disease risk reduction. Nutr Rev 68, 571-603, 2010.
7. Nurmi T, Mursu J, Peñalvo JL, Poulsen HE, and Voutilainen S: Dietary intake and urinary excretion of lignans in Finnish men. Br J Nutr 103, 677-685, 2010.
8. Owen RW, Mier W, Giacosa A, Hull WE, Spiegelhalder B, et al.: Identification of lignans as major components of the phenolic fraction of olive oil. Clin Chem 46, 976-988, 2000.
9. Andjelkovic M, Van Camp J, Pedra M, Renders K, Socaciu C, et al.: Correlations of the phenolic compounds and the phenolic content in some Spanish and French olive oils. J Agric Food Chem 56, 5181-5187, 2008.
10. Sok DE, Cui HS, and Kim MR: Isolation and bioactivities of furfuran type lignan compounds from edible plants. Recent Pat Food Nutr Agric 1, 87-95, 2009.
11. HuangDM, Guh JH, Chueh SC, and Teng CM: Modulation of anti-adhesion molecule MUC-1 is associated with arctiin-induced growth inhibition in PC-3 cells. Prostate 59, 260-267, 2004.
12. Yoo JH, Lee HJ, Kang K, Jho EH, Kim CY, et al.: Lignans inhibit cell growth via regulation of Wnt/beta-catenin signaling. Food Chem Toxicol 48, 2247-2252, 2010.
13. Peuhu E, Rivero-M̈uller A, Stykki H, Torvaldson E, Holmbom T, et al.: Inhibition of Akt signaling by the lignan matairesinol sensitizes prostate cancer cells to TRAIL-induced apoptosis. Oncogene 29, 898-908, 2010.
14. Bylund A, Saarinen N, Zhang JX, Bergh A, Widmark A, et al.: Anticancer effects of a plant lignan 7-hydroxymatairesinol on a prostate cancer model in vivo. Exp Biol Med 230, 217-223, 2005.
15. Yokota T, MatsuzakiY,KoyamaM,Hitomi T, Kawanaka M, et al.: Sesamin, a lignan of sesame, down-regulates cyclin D1 protein expression in human tumor cells. Cancer Sci 98, 1447-1453, 2007.
16. Chin YW, Chai HB, Keller WJ, and Kinghorn AD: Lignans and other constituents of the fruits of Euterpe oleracea (Açai) with antioxidant and cytoprotective activities. J Agric Food Chem 56, 7759-7764, 2008.
17. Kuo PC, LinMC, Chen GF,Yiu TJ, and Tzen JT: Identification ofmethanolsoluble compounds in sesame and evaluation of antioxidant potential of its lignans. J Agric Food Chem 59, 3214-3219, 2011.
18. Jung HM, Mahesh R, Lee JG, Lee SH, Kim YS, et al.: Pinoresinol from the fruits of Forsythia koreana inhibits inflammatory responses in LPSactivated microglia. Neurosci Lett 480, 215-220, 2010.
19. Kim HY, Kim JK, Choi JH, Jung JY, OhWY, et al.: Hepatoprotective effect of pinoresinol on carbon tetrachloride-induced hepatic damage in mice. J Pharmacol Sci 112, 105-112, 2010.
20. Kwak JH, Kang MW, Roh JH, Choi SU, and Zee OP: Cytotoxic phenolic compounds from Chionanthus retusus. Arch Pharm Res 32, 1681-1687, 2009.
21. Moon SS, Rahman AA, Kim JY, and Kee SH: Hanultarin, a cytotoxic lignin as an inhibitor of actin cytoskeleton polymerization from the seeds of Trichosanthes kirilowii. Bioorg Med Chem 16, 7246-7249, 2008.
22. Mimaki Y, Kuroda M, Asano T, and Sashida Y: Triterpene saponins and lignans from the roots of Pulsatilla chinensis and their cytotoxic activity against HL-60 cells. J Nat Prod 62, 1279-1283, 1999.
23. Fini L, Hitchkiss E, Fogliano V, Graziani G, et al.: Chemopreventive properties of pinoresinol-rich olive oil involves a selective activation of the ATM-p53 cascade in colon cancer cell lines. Carcinogenesis 29, 139-146, 2008.
24. Fabiani R, Sepporta MV,Mazza T, Rosignoli P, Fuccelli R, et al.: Influence of cultivar and concentration of selected phenolic constituents on the in vitro chemiopreventive potential of olive oil extracts. J Agric Food Chem 59, 8167-8174, 2010.
25. Lozano-Śanchez J, Segura-CarreteroA,Menendez JA, Oliveras-FerrarosC, Cerretani L, et al.: Prediction of extra virgin olive oil varieties through their phenolic profile. Potential cytotoxic activity against human breast cancer cells. J Agric Food Chem 58, 9942-9955, 2010.
26. Grimaudo S, TolomeoM, Chimirri A, Zappal̀aM, Gancitano RA, et al.: Selective induction of apoptosis in multidrug resistant HL60R cells by the thiazobenzoimidazole derivative 1-(2,6-difluorophenyl)-1H,3H-thiazolo [3,4-a] benzimidazole (TBZ). Eur J Cancer 34, 1756-1763, 1998.
27. Hussain RF, Nouri AM, and Oliver RT: A new approach for measurement of cytotoxicity using colorimetric assay. J Immunol Methods 160, 89-96, 1993.
28. Tsiftsoglou AS, Pappas IS, andVizirianakis IS:Mechanisms involved in the induced differentiation of leukemia cells. Pharmacol Ther 100, 257-290, 2003.
29. Guerrini A, Lampronti I, Bianchi N, Zuccato C, Breveglieri G, et al.: Bergamot (Citrus bergamia Risso) fuit extracts as ?-globin gene expression inducers: phytochemical and functional perspectives. J Agric Food Chem 57, 4103-4111, 2009.
30. Dotto GP: p21(WAF1/Cip1): more than a break to the cell cycle?. Biochim Biophys Acta 1471, M43-M56, 2000.
31. Chen LH, Fang J, Li H, Demark-Wahnefried W, and Lin X: Enterolactone induces apoptosis in human prostate carcinoma LNCaP cells via a mitochondrial-mediated, caspase-dependent pathway. Mol Cancer Ther 6, 2581-2590, 2007.
32. Chen LH, Fang J, Sun Z, Li H, Wu Y, et al.: Enterolactone inhibits insulinlike growth factor-1 receptor signaling in human prostatic carcinoma PC-3 cells. J Nutr 139, 653-659, 2009.
33. Balijepalli MK, Tandra S, and Pichika MR: Antiproliferative activity and induction of apoptosis in estrogen receptor-positive and negative human breast carcinoma cell lines by Gmelina asiatica roots. Pharmacognosy Res 2, 113-119, 2010.
34. Lehraiki A, Attoumbŕe J, Bienaiḿe C, Matifat F, Bensaddek L, et al.: Extraction of lignans from flaxseed and evaluation of their biological effects on breast cancer MCF-7 and MDA-MB231 cell lines. J Med Food 13, 834-841, 2010.
35. Welshons WV, Murphy CS, Koch R, Calaf G, and Jordan VC: Stimulation of breast cancer cells in vitro by the environmental estrogen enterolactone and the phytoestrogen equol. Breast Cancer Res Treat 10, 169-175, 1987.
36. Torres-Sanchez L, Galvan-Portillo M, Wolff MS, and Lopez-Carillo L: Dietary consumpion of phytochemicals and breast cancer risk in Mexican women. Public Health Nutr 12, 825-831, 2009.
37. Zhou P, Yao Y, Soh JW, and Weinstein IB: Overexpression of p21Cip1 or p27Kip1 in the promyelocytic leukemia cell line HL60 accelerates its lineage-specific differentiation. Anticancer Res 19, 4935-4945, 1999.
38. Horie N, Mori T, Asada H, Ishikawa A, Johnston PG, et al. Implication of CDK inhibitors p21 and p27 in the differentiation of HL60 cells. Biol Pharm Bull 27, 992-997, 2004.
39. Steiner M, Priel I, Giant J, Levy J, Sharoni Y, and Danilenko M: Carnosic acid inhibits proliferation and augment differentiation of human leukemic cells induced by 1,25-fihydroxyvitamin D3 and retinoic acid. Nutr Cancer 41, 135-141, 2001.
40. Lee KW, Kim HJ, Lee YS, Park HJ, Choi JW, et al.: Acteoside inhibits human promyelocytic HL-60 leukemia cell proliferation via inducing cell cycle arrest at G0/G1 phase and differentiation into monocytes. Carcinogenesis 28, 1928-1936, 2007.
41. Tang H, Chen F, Tan Q, Tan S, Liu L, et al.: Regulation of CD11b transcription by decreasing PRC2 and increased acH4 level during ATRAinduced HL60 differentiation. Acta Biochim Biophys Sin 41, 588-593, 2009.
42. Wang X and Studzinski GP. Activation of extracellular signal-regulated kinases (ERKs) defines the first phase of 1,25-dihydroxyvitamin D3-induced differentiation of HL60 cells. J Cell Biochem 80, 471-482, 2001.
43. Peeters PH, Slimani N, van der Schouw YT, Grace PB, Navarro C, et al.: Variations in plasma phytoestrogen concentrations in European adults. J Nutr 137, 1294-1300, 2007.
44. Peñalvo JL, Nurmi T, Haajanen K, Al-Maharik N, BottingN, et al.:Determination of lignans in human plasma by liquid chromatography with coulometric electrode array detection. Analytical Biochemistry 332, 384-393, 2004.
45. Morton MS, Chan PS, Cheng C, Blacklock N, Matos-Ferreira A, et al.: Lignans and isoflavonoids in plasma and prostatic fluid in men: samples from Portugal, Hong Kong, and the United Kindom. Prostate 32, 122-128, 1997.